Regulatory

‘We Consider This to Be Our New Normal’: Behavioral Health Leaders Go to Bat for Telehealth Prescribing in Front of DEA

Several behavioral health executives shared their thoughts on the Drug Enforcement Administration’s (DEA) proposed rules for controlled substances and telehealth on Tuesday, with most going to bat for virtual-prescribing practices in front of agency officials. Tuesday brought the first of two listening sessions to discuss what potential post-COVID regulations for telehealth prescribing could and should …

‘We Consider This to Be Our New Normal’: Behavioral Health Leaders Go to Bat for Telehealth Prescribing in Front of DEA Read More »

Provider Groups Warn Proposed Medicare Payment Cuts Will Pinch Docs, Hamper Access to Care

Provider groups are urging the Biden administration to reconsider proposed cuts to physician payments in its annual fee schedule rule, arguing that the cuts could force service and staffing reductions as practices feel the financial pinch. “The proposed cuts are bad policy, bad timing and bad for patients. Physicians are facing a triple whammy as …

Provider Groups Warn Proposed Medicare Payment Cuts Will Pinch Docs, Hamper Access to Care Read More »

2 Health System M&A Deals Disrupting Their Markets: Will They Fail?

The Wisconsin and Oregon healthcare markets have two merger deals that could completely disrupt their competitive markets if they go through. But will the FTC give these deals the green light? Read the full article: 2 Health System M&A Deals Disrupting Their Markets: Will They Fail? // Source: https://www.healthleadersmedia.com/strategy/2-health-system-ma-deals-disrupting-their-markets-will-they-fail

Hospitals Push FTC to Withdraw ‘Largely Unnecessary’ Updates to Pre-Merger Regulatory Filings

The American Hospital Association (AHA) is among those pushing back against the Federal Trade Commission’s (FTC’s) plans to update pre-merger notification requirements, calling the proposal “a substantial burden” that’s “largely unnecessary” for effective antitrust review of the hospital industry. In a comment letter submitted Tuesday, the major hospital lobby said it shared many of the …

Hospitals Push FTC to Withdraw ‘Largely Unnecessary’ Updates to Pre-Merger Regulatory Filings Read More »

The FTC Cleared Amgen’s $27.8B Horizon Buyout — Here’s What It Means for Other Massive Pharma Deals

The Federal Trade Commission last week allowed Amgen to move forward with its $27.8 billion acquisition of Horizon Therapeutics under a settlement agreement – a move that could have ramifications for a string of other pharmaceutical industry buyouts. Some Wall Street analysts said the FTC’s decision to settle allows the sector to breathe a sigh …

The FTC Cleared Amgen’s $27.8B Horizon Buyout — Here’s What It Means for Other Massive Pharma Deals Read More »

Attorney General Bonta Joins Historic FTC Settlement with Major Pharma Company Amgen

California Attorney General Rob Bonta has announced joining the Federal Trade Commission (FTC) in a groundbreaking settlement with Amgen, one of the world’s largest biopharmaceutical drug companies. The settlement resolves a lawsuit filed by the FTC and California, alleging Amgen’s proposed acquisition of Horizon Therapeutics (Horizon) would allow it to virtually monopolize the market for …

Attorney General Bonta Joins Historic FTC Settlement with Major Pharma Company Amgen Read More »

Scroll to Top